Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in REPL — Replimune Group, Inc.

CIK 1423053 MIAMI, FL
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$8,681,459
+$5,631,183 QoQ
Shares Held
784,233
+96.7% QoQ
Ownership
0.832%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Derivatives in REPL

reported options exposure · as of Jun 30, 2026
CallValue
$7,501,032
CallShares
677,600
PutValue
$5,163,048
PutShares
466,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. REPL ranks #108 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in REPL

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,501,032 677,600
2026-06-30 $5,163,048 466,400
2026-06-30 $8,681,459 784,233
2026-03-31 $1,889,550 247,000
2026-03-31 $1,362,465 178,100
2026-03-31 $3,050,276 398,729
2025-12-31 $1,539,248 158,359
2025-12-31 $2,431,944 250,200
2025-12-31 $987,552 101,600
2025-09-30 $503,771 120,232
2025-09-30 $1,068,450 255,000
2025-09-30 $1,633,262 389,800
2025-06-30 $2,577,733 277,474
2025-06-30 $1,412,080 152,000
2025-06-30 $1,501,264 161,600
2025-03-31 $610,350 62,600
2025-03-31 $221,861 22,755
2025-03-31 $94,575 9,700
2024-12-31 $96,880 8,000
2024-12-31 $41,174 3,400
2024-12-31 $1,651,367 136,364
2024-09-30 $1,488,137 135,779
2024-09-30 $111,792 10,200
2024-09-30 $139,192 12,700
2024-06-30 $36,900 4,100
2024-06-30 $1,933,974 214,886
2024-06-30 $82,800 9,200
2024-03-31 $227,126 27,800
2024-03-31 $148,694 18,200
2024-03-31 $550,984 67,440
2023-12-31 $148,368 17,600
2023-12-31 $1,749,536 207,537
2023-12-31 $612,018 72,600
2023-09-30 $1,786,284 104,400
2023-09-30 $20,481,268 1,197,035
2023-09-30 $1,904,343 111,300
2023-06-30 $26,380,659 1,136,118
2023-06-30 $297,216 12,800
2023-06-30 $631,584 27,200
2023-03-31 $121,854 6,900
2023-03-31 $19,689,345 1,114,912
2023-03-31 $49,448 2,800
2022-12-31 $27,200 1,000
2022-12-31 $15,122,547 555,976
2022-12-31 $2,325,600 85,500
2022-09-30 $11,156,816 646,023
2022-09-30 $1,471,404 85,200
2022-06-30 $10,196,380 583,317
2022-06-30 $1,424,620 81,500
2022-03-31 $5,740,173 338,055